| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.097 | 0.1 |